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Abstract
Background: The cause of sporadic amyotrophic lateral sclerosis (ALS) is largely unknown but hypotheses about
disease mechanisms include oxidative stress, defective axonal transport, mitochondrial dysfunction and disrupted
RNA processing. Whereas familial ALS is well represented by transgenic mutant SOD1 mouse models, the mouse
mutant wobbler (WR) develops progressive motor neuron degeneration due to a point mutation in the Vps54
gene, and provides an animal model for sporadic ALS. VPS54 protein as a component of a protein complex is
involved in vesicular Golgi trafficking; impaired vesicle trafficking might also be mechanistic in the pathogenesis of
human ALS.
Results: In motor neurons of homozygous symptomatic WR mice, a massive number of endosomal vesicles
significantly enlarged (up to 3 μm in diameter) were subjected to ultrastructural analysis and
immunohistochemistry for the endosome-specific small GTPase protein Rab7 and for amyloid precursor protein
(APP). Enlarged vesicles were neither detected in heterozygous WR nor in transgenic SOD1(G93A) mice; in WR
motor neurons, numerous APP/Rab7-positive vesicles were observed which were mostly LC3-negative, suggesting
they are not autophagosomes.
Conclusions: We conclude that endosomal APP/Rab7 staining reflects impaired vesicle trafficking in WR mouse
motor neurons. Based on these findings human ALS tissues were analysed for APP in enlarged vesicles and were
detected in spinal cord motor neurons in six out of fourteen sporadic ALS cases. These enlarged vesicles were not
detected in any of the familial ALS cases. Thus our study provides the first evidence for wobbler-like aetiologies in
human ALS and suggests that the genes encoding proteins involved in vesicle trafficking should be screened for
pathogenic mutations.
Background
Neurodegenerative processes cause dramatic but heteroge-
neous disease phenotypes depending on the onset of
symptoms, disease progression and the particular type of
neurons being affected. In the case of “Amyotrophic Lat-
eral Sclerosis” (ALS) the motor neurons of the motor
cortex, brain stem and spinal cord are affected. The degen-
eration of motor nerves causes denervation of skeletal
muscle and progressive muscular weakness leading even-
tually to paralysis and death. Despite intensive research no
effective therapeutic treatment is available but recently
some progress has been made in the understanding of the
underlying molecular mechanisms of ALS.
The majority of neurodegenerative disorders are asso-
ciated with abnormal protein aggregation. Aggregates of
amyloidogenic cleavage products of amyloid precursor
protein (APP) are implicated in the pathogenesis of
Alzheimer disease (AD, recently reviewed by [1]).
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cles in Niemann Pick Disease type C (NPC) [2] and
recently found to be elevated in skeletal muscles of ALS
patients as well as SOD1-G93A mutant transgenic mouse
[3]. For these reasons we elected to investigate APP accu-
mulation in the wobbler mouse, another animal model
for human ALS with a different pathomechanism.
The recessive wobbler mutation (wr =g e n es y m b o l ,
phenotype WR) spontaneously occurred 50 years ago in
the breeding stock of Falconer [4] and was later mapped
to the proximal mouse chromosome 11 [5]. Homozy-
gous (wr/wr) wobbler mice develop the first disease
symptoms at the age of three to four weeks. From this
time point onwards the muscle weakness, beginning in
the forelegs, proceeds to death. The life expectancy of
homozygous WR mice is around 120 days. Degeneration
of WR motor neurons is accompanied by activation of
glia cells (reactive gliosis and microglia activation) and
shows striking similarities to early-onset ALS cases. The
phenotype of the wobbler mouse has been intensively
investigated throughout the last 50 years and studies
towards potential therapies have been conducted.
A positional cloning of the wobbler gene revealed a
highly conserved vesicle trafficking factor, Vps54 [6].
The wobbler mutation is a point mutation leading to an
amino acid replacement (Q967L) in the C-terminal
domain of Vps54 causing the ALS-like motor neuron
degeneration. We also demonstrated that the complete
loss of Vps54 function leads to embryonic lethality
around day 11.5 of embryonic development [6].
Yeast, as well as mammalian Vps54 forms a complex
with Vps52 and Vps53, called GARP (Golgi associated
retrograde protein) complex [7,8], which is required for
tethering and fusion of endosome-derived transport
vesicles to the trans-Golgi network (TGN) [9]. The
GARP complex tethers vesicles to their target mem-
brane (TGN) leading to a t-SNARE - v-SNARE depen-
dent fusion of the membranes. In mammalian cells,
Vps52 interacts with the tSNARE Syntaxin10 and the
small GTP binding protein Rab6 [8]. In wobbler mice,
mutation of leucine-967 to glutamine causes instability
of an alpha helical structure, leading to reduced levels of
Vps54 and consequently, the GARP complex [9]. In this
s t u d yw ec h a r a c t e r i s ea b n o r mally enlarged endosomal
vesicles in wobbler spinal cord motor neurons and pro-
vide evidence that similar vesicles can be found in
motor neurons of a subset of human ALS cases. These
findings provide evidence for morphological criteria that
could be used to classify human MND.
Results
Fine structure of WR motor neurons
To analyse the consequence of impaired vesicle traffick-
ing in WR motor neurons, light (Figure 1A&B) and
electron microscopy (EM, Figure 1C-J) of spinal cord
sections from symptomatic wobbler (42 d.p.n.) and age-
matched unaffected controls (heterozygous wr/+)w a s
performed. In wobbler spinal cord, a small fraction of
motor neurons is symptomatic for neurodegeneration,
judged by morphological changes ranging from
early vacuolisation to obvious neuronal cell death
(Figure 1A&1B). Degeneration stages were classified
based on Nissl staining as described earlier [10]. Though
nuclear morphology changes from distinct rounded con-
tours to slightly irregular ones (Figure 1A&1C), no
change in nuclear morphology, as characteristic for
apoptosis or necrosis can be observed, even at later
stages of degeneration. Changes at the ultra structural
level are transparent enlarged vesicles / vacuoles which
are derived from the Golgi apparatus (Figure 1G&1H).
In more advanced stages of degeneration, these vacuoles
increase in size and become more frequent (Figure 1I).
A second type of vacuoles, according to their position
and their association with ribosomes, appear to originate
from dilatation of the endoplasmic reticulum (ER), as
demonstrated in earlier stages (postnatal day 7 to 14) of
the wobbler disease [11]. At terminal stages, motor neu-
ron degeneration is characterized by extensive vacuolisa-
tion (Figure 1A, C, E, J) with vacuoles graded from
smaller up to extremely large (2-3 μm diameter) ones
(Figure 1C, E, J). Initially, areas with strong vacuolisation
seem to be localized in one region of the cell (Figure 1C,
E) but later they are found all over the motor neuronal
soma (Figure 1A) obviously sparing the axon and the
axon hillock. No difference in number and distribution
of lysosomes was observed between wobbler and wild-
type motor neurons (Figure 1C, D, E, F).
Rab7 and APP colocalise in enlarged endosomal
structures in wobbler spinal cord motor neurons
As demonstrated earlier, the small GTPase protein Rab7
has a role in late endosomal pathway and in the final
maturation of autophagic vesicles [12]. The wobbler
mutation causes impaired retrograde transport of vesi-
cles. Thus we speculated that Rab7 might be expressed
differently in wobbler motor neurons. Spinal cord sec-
tions from unaffected heterozygous (genotype wr/+) and
wobbler (WR, genotype wr/wr)m i c ew e r es t a i n e df o r
Rab7 (Figure 2B, E) and revealed enlarged vesicles in
wobbler motor neurons compared to wild-type controls.
Interestingly, staining for APP, an abundant membrane
protein, which is transported via the secretory pathway,
showed an identical localisation as Rab7 preferentially in
endosomes (Figure 2A, D), indicating that APP and
Rab7 are co-localised in enlarged vesicles in wobbler
motor neurons (Figure 2F). This type of co-localisation
was only seen in degenerating motor neurons, whereas
morphologically normal motor neurons showed no such
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Page 2 of 10Figure 1 Fine structure of wobbler and WT motor neurons. (A) Terminal stage of WR motor neuron. Note extensive vacuolisation but
normal shape of cell bodies and non-necrotic and non-apoptotic nucleus (N). (B) Intact WR motor neuron from contralateral side of same
section as in (a) with Nissl-Golgi areas (darker blue areas) within the cell body. (C) Terminal stage of motor neuron death in WR is characterized
by extensive vacuolisation but otherwise intact organelle structure, frequency and distribution. (D) Motor neuron from age-matched WT,
lysosomes discernible (as in C) as deep-black organelles. (E, F) Camera lucida sketch of wr terminal stage (E) and of intact motor neuron from
wildtype (F); vacuoles highlighted in red, lysosomes in blue. (G, H) Earliest changes are observed by clear enlarged vesicles / vacuoles
(arrowhead) derived from Golgi apparatus. (I) Later stage of motor neuron death is characterized by massive vacuolisation of Golgi apparatus
(arrowheads) and additionally by vacuolisation/dilatation of ER with grey electron dense content (cytoplasm; arrows). (J) Final stage of motor
neuron death with numerous and large vacuoles but mainly intact mitochondria. N = nucleus; c = capillary; ah = axon hillock, m =
mitochondrion. Scale in B (for A &B), 10 μm; in D (for C & D), in F (for E & F), and J (G-J), 1 μm, respectively.
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Page 3 of 10abnormalities. In addition, spinal cord motor neurons
from symptomatic SOD1 tg (G93A) mice (120 d.p.n.)
exert a vesicular distribution of APP and Rab7 distinct
from the observations made in WR motor neurons
(Figure 2G, H, J). The enlarged vesicles characterised by
EM and by APP immunohistochemistry (IHC) were
subjected to image analysis to quantify cross-sectional
vesicular diameters in wildtype, wobbler, and SOD1 tg
(G93A) mice (Figure 3). A significant difference
was seen in endosomal diameters in wild-type and
wobbler motor neurons, both by EM and by IHC to a
similar extent (0.5 μmv s .2 . 5μm, and 0.8 vs. 3 μm,
respectively), whereas the endosomes in SOD1 tg (G93A)
motor neurons were only slightly enlarged (1 μmv s
0.8 μm in WT, p < 0.001), supporting the notion that
large endosomal aggregates are indicative for the WR
disease with impaired vesicle trafficking.
Distinct localisation of APP and LC3 in degenerating
motor neurons
To test the hypothesis that enlarged vesicles in WR motor
neurons could be autophagosomes, co-stains of APP and
LC3 were performed in a representative motor neuron
with normal (WT, Figure 4A, B, C) and with degenerating
Figure 2 APP and Rab7 colocalise in degenerating motor neurons. Representative immunohistochemical staining for Amyloid-Precursor
Protein (APP) (A,D,G) using rabbit anti-APP, and for Rab7 (B,E,H) using goat-anti-Rab7, and co-localisation of both proteins (C,F,I) in spinal cord
motor neurons of 42 d.p.n. wild-type (WT, A,B,C), age-matched wobbler (WR, D,E,F), and 120 d.p.n. SOD1G93A (G,H,I) transgenic mice. Note the
spotty appearance of the large vesicular structures with up to 2.5 μm diameter in WR sections. These structures were not seen in WT and in
SOD1 (G93A) transgenic spinal cord sections. Bar in A, valid for A-I, 5 μm.
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Page 4 of 10morphology (WR, Figure 4D, E, F). In both motor neuron
populations, LC3-positive vesicles were indistinguishable
in size and number between WT and WR, and most of
APP-positive large vesicles in wobbler motor neurons did
not stain for LC3 and vice versa (Figure 4C, F). We con-
clude that the abnormally enlarged vesicles in WR motor
neurons are distinct from autophagosomes.
Analysis of APP processing in brain stem and spinal cord
of wild-type and wobbler mice
Accumulation of APP could be due to abnormal secre-
tase processing. Due to a distinct expression of APP in
motor neurons in the spinal cord (see Figure 2) we ana-
lysed brain stem and spinal cord protein extracts from
WT and WR mice for expression levels of APP, LC3
and Rab7 (Figure 5). Significant increases in APP, LC3
and Rab7 protein levels were detected in WR brain stem
and spinal cord lysates compared to WT. No APP pro-
cessing products, however, were detected, suggesting
that accumulation of APP is not due to abnormal pro-
cessing in WR motor neurons. The levels of LC3
expression is higher in WR spinal cord, however the
ratios of LC3I (18kD) and LC3II (16kD) were
unchanged, indicating that autophagosome activation is
not affected. For Rab7 protein, a slight increase in WR
spinal cord was also observed, concomitant with the
observation of endosome accumulation in WR motor
neurons (Figure 2). With respect to APP processing, we
stained WT and WR spinal cord sections for the secre-
tases ADAM10 and BACE, but neither a difference in
distribution nor in concentration was detected (data not
shown).
APP-positive enlarged vesicles in human MND/ALS
autopsies
From these previous results we concluded that the pre-
sence of enlarged APP-positive vesicles could be indica-
tive for motor neuron diseases with impaired retrograde
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Figure 3 Enlarged vesicles in WR motor neurons. Quantification
of vesicle diameters in WT, WR and SOD1 (G93A) tg motor neurons,
judged by electron microscopy (WT, WR) and by
immunohistochemistry (WT, WR, SOD1 (G93A)tg). Cross-sectional
vesicle diameters were determined by ImageJ analysis (see M&M
section) for 100 different APP-positive motor neurons in serial
cervical spinal cord sections (n = 10 per genotype, 10 sections per
individual) from WR, WT, and SOD1 (G93A) tg mice, respectively.
Values are given as mean values ± SD. P-values < 0.01 between WT,
WR, and SOD1(G93A) were considered significant with *, p < 0.01
and **, p < 0.001.
Figure 4 APP/LC3 immunohistochemistry in WR motor
neurons. Immunostaining for APP (A,D; green) using rabbit-anti-APP
and mouse-anti-LC3 (B,E; red) performed in either WT (A,B) or WR
(D,E) motor neurons in cervical spinal cord (42 d.p.n.). Note a similar
number of autophagosomes in B and E (arrowheads). Arrows in D
indicates large APP-positive vesicles. Merged images in C and F
demonstrate that APP and LC3 are localised to distinct vesicles in
degenerating motor neurons. Bar in A, valid for A-E, 10 μm.
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Figure 5 APP processing in WR spinal cord. Western blot analysis
of brain stem (BS) and spinal cord (SC) lysates from age-matched
WT and WR mice. Total lysates (20 μg per lane) were separated on
an 8% polyacrylamide gel, blotted and subjected to
immunostaining using 22C11 (APP), LC3 and Rab7 as described. The
positions of APP695 and APP770, of LC3I (18kD form) and LC3II (16
kD form) and Rab7 (22 kD) are marked on the left. Anti-tubulin
antibody (lower panel) was used as loading control. Band intensities
for APP695, LC3II and Rab7 were quantified from 3 independent
experiments and plotted as ratio WR/WT ± SEM. For each WT/WR
pair, the WT value was set to 1.
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Page 5 of 10protein transport. We analysed a collection of human
MND autopsy samples with well-documented case his-
tories but unknown aetiologies for the presence of APP
positive enlarged vesicles after immunohistochemistry
( F i g u r e6a n dT a b l e1 ) .F r o mf o u r t e e nd o c u m e n t e d
MND cases investigated, six MND cases displayed
enlarged vesicles in spinal cord motor neurons. Two
familial MND cases with mutations in the SOD gene did
not exert enlarged vesicles, which could match our find-
ings in SOD1(G93A) motor neurons and implies that
SOD1 mutations are distinct in motor neuron degenera-
tion mechanisms from the sporadic ALS cases with
impaired trafficking that we investigated here. Motor
neurons with enlarged vesicles were found in individual
motor neurons in the spinal cord of autopsies with ALS
or Motor neurons disease (MND), a representative
example of this staining is shown (Figure 6). Analyses of
APP immunoreactivity in MND patients in optical z-
and y-axes revealed that APP is present in vesicle struc-
tures with diameters of 1.5-4 μm (average 2.8 μm), very
similar to the dimensions of enlarged APP-positive vesi-
cles observed in WR motor neurons.
Sequence analysis of Vps54 gene of ALS patients
Genomic DNAs of all six ALS patients with wobbler-like
enlarged endosomal structures as well as controls were
prepared from cerebellum samples. All exons of human
VPS54 were amplified including flanking regions, and
sequenced in both orientations. In none of the samples
a n dn o n eo ft h eV P S 5 4e x o n sas e q u e n c ev a r i a t i o n
could be detected, thus, no mutation or polymorphism
could be found in the VPS54 gene of the selected ALS
patients.
Discussion
Our study demonstrates that impaired retrograde trans-
port as observed in wobbler motor neurons is character-
ized by the presence of enlarged endosomal vesicles
with positive immunostaining for Rab7 and APP, but
not for LC3. As such, the type of motor neuron degen-
eration as observed in WR does not involve autophago-
somes. These findings contrast those for motor neurons
of SOD1(G93A) mice where extensive autophagosome
activation has been demonstrated [13]. It is unlikely that
the vesicular accumulation of APP is instrumental for
motor neuron degeneration in the wobbler mouse, as
APP transgenic mice crossed into the wobbler mutation
did not enhance motor neuron pathology (Schmitt-John
et al, unpublished observations).
Characteristic signs of motor neuron death in wobbler
are enlarged vesicles blebbing of the Golgi apparatus,
increasing in size and number in later stage as well as
enlarged vesicles/vacuoles derived from the ER, in agree-
ment with earlier EM studies performed on wobbler
motor neurons [11]. With the exception of this vacuoli-
sation, the affected motor neuron seems to be viable
just up to the terminal breakdown. The ultrastructural
data indicate that the vesicular shuttle system of ER and
Golgi and perhaps of lysosomes (GERL-system) is
affected. This would be in agreement with the fact that
in wobbler mice the vesicular transport factor VPS54, a
component of the GARP complex, is mutated [6]. In
particular, vacuolisation in close proximity to the Golgi
apparatus seen on electron micrographs of wobbler
motor neurons reflects the function of the GARP com-
plex involved in tethering endosome-derived retrograde
vesicles to the Golgi membrane as shown in yeast [7],
but also in mammalian cells [14].
Immunofluorescence data indicate an intracellular
accumulation of APP in Rab7- but not LC3-positive
endosomal compartments in degenerating wobbler
motor neurons. Intracellular APP accumulations have
earlier been reported for Niemann Pick Disease type 1
(NPC1), where APP was found in Rab5-positive early
endosomes rather than in Rab7 positive late endosomes
[2]. Furthermore, Jin et al. [2] found elevated, proteolyti-
cally processed APP (C99 and Ab42) in NPC1 neurons.
The western blotting data suggest that in wobbler spinal
cords APP is upregulated but no indications for abnor-
mal APP proteolysis have been found indicating poten-
tial amyloid accumulations. Thus, we conclude that the
wobbler vesicle trafficking defect leads to an accumula-
tion of native APP variants in abnormally enlarged APP
+/Rab7
+ endosomal compartments.
Figure 6 APP staining in the spinal cord of human ALS
autopsies. Representative (case No. 12 see table 1 for details)
degenerating human motor neuron with enlarged APP-positive
vesicles in the cell soma. For comparison, a morphologically normal
spinal cord motor neuron from the same autopsy is shown above
(arrow). (A), a single plane image, (B) and (C), maximum projections
from a stack of images obtained from confocal optical sectioning.
(A), low magnification of MND spinal cord section stained with anti-
APP. (B), high power magnification of the normal MN shown in (A),
as a xy- (middle), yz- (left) and xz- (top) scan with diffuse staining of
APP in the cell soma; (C), high power magnification of the
degenerating MN shown in A, as an xy- (middle), yz- (left) and xz-
(top) scan with enlarged vesicles, some of them larger than 2 μm
(see crossing point of the planes in C with a vesicle diameter of 2.8
μm. The yz- and xz-scans reveal the three-dimensional APP-positive
vesicles in the degenerating human motor neuron. Scale bar in (A),
50 μm.
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Page 6 of 10The average cross-sectional diameter of these com-
p a r t m e n t si s3μm and significantly larger than APP-
and Rab7-positive structures in wild-type or SOD1
transgenic mice. The ultrastructural equivalents are
vacuoles with low electron density and a size of up to
3 μm. These vacuoles most likely are derived from the
Golgi and the ER. Since the occurrence of such struc-
tures is found in wobbler, but not in SOD1 and wild
type mice these are likely caused by impaired bidirec-
tional vesicle traffic between ER and Golgi. Again, these
findings are in agreement with the function of Vps54
and the GARP complex as recently demonstrated [14].
Enlarged APP
+/Rab7
+ endosomes were also found in
MDF ("muscle deficient”)s p i n a lc o r dm o t o rn e u r o n s .
Recently, the mutation underlying the mouse mutant
MDF has been revealed as scyl1, a gene that affects Golgi
transport and morphology [15] (see additional file 1),
confirming that vesicular APP/Rab7 staining indeed
reflects transport impairment in motor neurons.
Extending our analysis to human MND were able to
identify APP
+/Rab7
+ vesicles in degenerating motor neu-
rons, which could indicate that in a subset of human MND,
retrograde vesicle trafficking is affected and could lead to
the identification of more MND relevant gene mutations.
Thus the correlation between vesicle trafficking defects and
ALS is obvious since the affected gene for familial ALS2
Alsin was found to encode a guanine-nucleotide exchange
factor for the vesicle traffic associated protein Rab5 [16,17]
and ALS8 encodes the vesicle associated membrane protein
B (VAPB, [18]). Besides these, several other vesicle traffick-
ing proteins have been associated with neurodegeneration
like Dynactin with Neuropathy distal hereditary motor type
VIIB (HMN7B, [19] and Phosphoinositide phosphatase
FIG4 in patients with ALS [20].
The VPS54 genes of some MND patients, preselected
for enlarged APP- and LC3-positive endosomal compart-
ments were sequenced, but so far, mutations or poly-
morphisms were not detected. A similar sequencing effort,
Table 1 APP
+ vesicle formation in MND autopsies
CASE # AGE GENDER PM [h] PATHOLOGICAL DIAGNOSIS DEG. APP+ VESICLES VPS54 SEQ. ALTERATION
1 74 M 83 MND -3 + n.d.
2 49 M 32 MND -3 - None
3 58 M 37 MND -2 - n.d.
4 69 F 17 MND -3 + n.d.
5 48 M 25 MND -2 + None
6 81 F 30 MND -2 - None
7 55 M 39 MND -2 - None
8 72 F 6 MND -1 - n.d.
9 68 F 70 MND -3 + None
10 54 M 30 MND -1 - n.d.
11 51 F 24 MND -3 + None
12 54 M 95 MND -2 + n.d.
13 54 F ? MND Familial -3 - n.d.
14 56 M 79 MND Familial -2 - n.d.
15 89 F 54 PD -1 - None
16 85 F 9 PD -2 - None
17 61 M 65 Amyloid plaques 0 - n.d.
18 79 M 24 Mild ageing changes 0 - n.d.
19 80 M 48 changes consistent with ageing 0 - n.d.
20 40 M 40 Normal adult brain 0 - n.d.
21 57 M 26 Normal adult brain 0 - n.d.
22 87 F 21 Normal adult brain 0 - None
23 68 M 53 Normal adult brain 0 - n.d.
24 64 F 60 Normal adult brain 0 - n.d.
25 61 M 35 Normal adult brain 0 - n.d.
26 58 F 21 Mild ischemia 0 - None
27 68 M 40 Diffuse hypoxic damage 0 - n.d.
28 61 M 65 None given 0 - n.d.
Legend: Histological assessment of human Motor neuron disease (MND) autopsies from spinal cord. Spinal cord sections were fixed in formalin after the post-
mortem time indicated ("PM”, in hours [h]) and later embedded in paraffin. The grades of Motor neuron degeneration were judged by Nissl staining and
designated as 0 (no degeneration), -1 (single degenerating neurons), -2 (more than one degenerating motor neuron per ventral horn), -3 (groups of degenerating
motor neurons). Note that in non-ALS brains including normal adult brain or other origins of neurodegeneration, APP
+ vesicles have not been detected.
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recently been published [21]. In this report a polymorph-
ism in VPS54 has been identified but could not be directly
associated with the disease. Thus up to now, mutations or
polymorphisms in VPS54 are not defined as a major cause
or a risk factor for sporadic forms of MND or ALS.
Conclusions
Our present study indicates that impaired vesicle traf-
ficking in MND mouse mutants is reflected by APP/
Rab7 accumulation in spinal cord motor neurons. Some
sporadic forms of human MND or ALS show similar
observations, so that assessment of APP localisation in
motor neurons could allow classification of human
aetiologies with impaired vesicle trafficking in order to
identify additional MND-relevant genes.
Methods
Mice
Breeding and genotyping of C57Bl/6J-wr and C57Bl/6J
stock mice was described earlier [6]. The SOD1 G93A
transgenic mice were obtained from M. Sendtner
(Würzburg University, Germany) and genotyped for the
SOD1 (G93A) transgene as described earlier [22]. Ani-
mal experimentation was done in accordance with the
German law for the protection of animals (TschG) and
with a permit by the local authorities.
Human samples
Human MND and control autopsy samples were derived
from the MRC London Neurodegenerative Diseases
Brain Bank (Institute of Psychiatry, King’s College Lon-
don) with an ethical approval from local authorities. The
case details including post mortem time before formalin
fixation or freezing of samples are provided in table 1.
Generally, post-mortem time had no effect on the forma-
tion of APP-positive vesicles, as spinal cord tissues from
wild-type mice were used as controls 120 hours post-
mortem time and no changes in vesicular APP was
observed (data not shown). Formalin fixed tissues were
embedded in paraffin according to standard procedures.
Immunohistochemistry
Cryosections of mouse CNS tissue (10 μm) were fixed
with 3.7% paraformaldehyde in phosphate buffered sal-
ine (PBS, 140 mM NaCl, 10 mM Na, K phosphate, pH
7.3). Paraffin sections from human autopsies (5 μm
thickness) were deparaffinised using xylene and varying
concentrations of ethanol before immunostaining.
For immunohistochemistry, anti-APP directed against
the extracellular domain (aa 301-315 of human APP,
Sigma A8842, 1:500) was used in conjunction with
anti-rabbit-Alexa 488 (1:500, MoBiTec); detection of
the endosomal protein Rab7 was performed using
goat-anti-Rab7 (SC-6563, Santa Cruz, 1:100) and mouse
anti-goat-Cy3 (Dianova, Hamburg, 1:300). Both primary
antibodies were used simultaneously in a single-label
experiment to avoid cross-reactivity. For autophagosome
detection, anti-LC3 antibody (1:200, Nanotools, Munich)
was used in conjunction with an anti-mouse Cy3 second-
ary antibody (1:1000, Sigma) and anti-APP described
above in a simultaneous incubation.
Fluorescence microscopy, confocal microscopy
Confocal images were obtained using Leica SP2 Confocal
Laser Scanning Microscope with software version 2.61
build 1537. Images were taken using either HCX PL APO
CS 63.0 × 1.32 OIL UV or HC PL APO CS 20.0 × 0.70
IMM/COR objectives. To acquire different fluorescence
channels settings were optimized to prevent cross-talk,
although images were sequentially scanned to avoid this
problem. All images were taken with 4 × line average at
data acquisition. Images were merged, and contrast and
brightness was enhanced using Leica software. Processing
of image stacks was done with Volocity software.
Electron Microscopy
Mice were anaesthetized and transcardially perfused
(with a permit from the local authorities) in a 3 step pro-
cedure slightly modified according to Forssmann et al
[23] with 3% paraformaldehyde, 3% glutaraldehyde, 0,5%
picric acid in 0.1 M sodium phosphate buffer, pH 7.4 for
10 minutes. The spinal cord was dissected and fixed in
the same solution for additional 1-2 hours at 4°C, post-
fixed in 2% osmium tetroxide (2 h, 4°C) and embedded in
Araldite resin. For light microscopic identification, sec-
tions of 1.5 μm thickness were stained with Richardson’s
blue (1% w/v methylene blue, 1% w/v Azur II) for 1 min,
80°C and visualised with a 100 × objective at a
Zeiss Axiophot microscope. For electron microscopy,
60-80 nm sections (stained for 40 min in uranyl acetate
and 7 min in lead citrate) were used (Zeiss EM 109).
Size determination of endosomal compartment
For quantification of vesicle areas we used the ImageJ
program http://rsb.info.nih.gov/ij/download.html. Images
were imported into image J, the scale was set to a
defined length for normalisation. Vesicles on the images
were determined for cross-sectional diameters [μm].
Data were obtained from a total of 100 motor neurons
from 10 spinal cord sections per individual (n = 10 per
genotype, age-matched 42 d.p.n.) and are presented as
mean ± SD. Significance was determined using a paired
t-test and values of p < 0.01 were considered significant.
Western Blot analysis
CNS tissues (cervical spinal cord and brain stem) were
removed quickly and homogenized in a buffer containing
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Page 8 of 10100 mM Tris-HCl, pH7.4, 1 mM EGTA, and Complete
Inhibitor Mix (Boehringer Mannheim). After addition of
Laemmli’s buffer, the protein extracts were denatured at
100°C for 5 min and separated on a 8% SDS-polyacryla-
mide gel. Proteins were immobilized by capillary blot on
a nitrocellulose membrane (Protran; Schleicher & Schüll,
Dassel, Germany). The transfer was checked by reversible
ponceau staining, and unspecific binding sites were
blocked overnight with blocking buffer [5% nonfat milk
powder in TTBS (20 mM Tris-HCl, pH 7.5, 500 mM
NaCl, and 0.05% Tween 20]. For detection of Amyloid-
Precuror protein APP in western blots, monoclonal
antibody 22C11 (Millipore, Watford, UK; 1:1000) was
incubated with the membranes for 4 hr at room tempera-
ture. Similarly, antibodies directed against LC3 (1:1000)
and Rab7 (1:200) were used. After extensive washing
(four times for 15 min each) with TTBS-0.5% non-fat
milk powder, membranes were incubated with either rat
anti-mouse (APP and LC3, 1:10000; Jackson ImmunoRe-
search, West Grove, PA) or rabbit anti-goat (Rab7,
1:2000) conjugated with horseradish peroxidase, respec-
tively, for 45 min. After washing (three times for 10 min
each) with TTBS, protein bands were detected with
Lumi-Light Plus Western blotting substrate (Roche
Applied Science) and Kodak X-OMAT film (Eastman
Kodak, Rochester, NY).
DNA preparation PCR amplification and sequencing
Genomic DNA from frozen cerebellum samples
(500 mg) of selected human patients and controls was
prepared by grinding in liquid nitrogen according to
standard protocols [24]. All 23 exons of human VPS54
gene were PCR amplified from 100 ng genomic DNA
using standard protocols, primer sequences and anneal-
ing temperatures can be obtained from Thomas
Schmitt-John upon request. PCR products were sepa-
rated on 1% agarose gels, bands excised and the DNA
was extracted using QiaQuick gel extraction kit (Qiagen,
Hilden). Gel-purified PCR products were subjected to
DNA sequencing using either forward or reverse PCR
primer, Big Dye 3 cycle sequencing and an ABI 3130 × l
sequencing machine (Applied Biosystems).
Additional material
Additional File 1: APP/Rab7 as a diagnostic marker for impaired
vesicle trafficking in MDF motor neurons. Immunohistochemical
staining for Amyloid-Precursor Protein (APP,A) using rabbit anti-APP, and
for Rab7 (B) using goat-anti-Rab7, and co-localisation of both proteins (C)
in spinal cord motor neurons of 60 d.p.n. MDF mice. Note the large
endosomal vesicles (arrows in C) staining positive for APP and Rab7,
indicating a transport impairment in these motor neurons, similar to the
ones observed in wobbler.
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